These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15370164)

  • 1. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations.
    Shields A; Lerman C; Sullivan P
    Nicotine Tob Res; 2004 Aug; 6(4):675-88. PubMed ID: 15370164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticipating clinical integration of genetically tailored tobacco dependence treatment: perspectives of primary care physicians.
    Park ER; Kleimann S; Pelan JA; Shields AE
    Nicotine Tob Res; 2007 Feb; 9(2):271-9. PubMed ID: 17365758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical, social and legal implications of genetic testing in liver disease.
    van Leeuwen DJ; Bernat JL
    Hepatology; 2006 Jun; 43(6):1195-201. PubMed ID: 16729331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics in dental practice: social and ethical issues surrounding genetic testing.
    Gettig E; Hart TC
    J Dent Educ; 2003 May; 67(5):549-62. PubMed ID: 12809190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and scientific considerations for chemoprevention research in cohorts at genetic risk for breast cancer.
    Nayfield SG
    J Cell Biochem Suppl; 1996; 25():123-30. PubMed ID: 9027608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ethical assessment framework for addressing global genetic issues in clinical practice.
    Cassells JM; Jenkins J; Lea DH; Calzone K; Johnson E
    Oncol Nurs Forum; 2003; 30(3):383-90. PubMed ID: 12719739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of nicotine addiction liability: ethical and social policy implications.
    Hall WD; Gartner CE; Carter A
    Addiction; 2008 Mar; 103(3):350-9. PubMed ID: 18190673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioethics for clinicians: 14. Ethics and genetics in medicine.
    Burgess MM; Laberge CM; Knoppers BM
    CMAJ; 1998 May; 158(10):1309-13. PubMed ID: 9614824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.
    Quaak M; van Schayck CP; Knaapen AM; van Schooten FJ
    Mutat Res; 2009 Jul; 667(1-2):44-57. PubMed ID: 19028511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation treatment: pharmacogenetic assessment.
    Munafò MR; Lerman C; Niaura R; Shields AE; Swan GE
    Curr Opin Mol Ther; 2005 Jun; 7(3):202-8. PubMed ID: 15977416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Family consent and the pursuit of better medicines through genetic research.
    Renegar G; Rieser P; Manasco P
    J Contin Educ Health Prof; 2001; 21(4):265-70. PubMed ID: 11803771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues concerning genetic testing and screening in public health.
    Hodge JG
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):66-70. PubMed ID: 14755435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study.
    Jenkins MM; Rasmussen SA; Moore CA; Honein MA
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):40-6. PubMed ID: 18189287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Categorizing genetic tests to identify their ethical, legal, and social implications.
    Burke W; Pinsky LE; Press NA
    Am J Med Genet; 2001; 106(3):233-40. PubMed ID: 11778984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Society and ethics - the genetics of disease.
    Thomas SM
    Curr Opin Genet Dev; 2004 Jun; 14(3):287-91. PubMed ID: 15172672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?
    Shields AE; Lerman C
    Clin Pharmacol Ther; 2008 Apr; 83(4):635-9. PubMed ID: 18323859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.